Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform: a retrospective longitudinal cohort study.

Saved in:
Bibliographic Details
Title: Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform: a retrospective longitudinal cohort study.
Authors: Tharpe C; Curex Inc, New York, NY, United States., Davidson J; Curex Inc, New York, NY, United States.; Pulmonary & Critical Care, BronxCare Health System, Chicago, IL, United States., Mardaga K; Curex Inc, New York, NY, United States., Solow C; Curex Inc, New York, NY, United States., Kakaulin G; Curex Inc, New York, NY, United States., Kruzick T; Curex Inc, New York, NY, United States., Herold J; Curex Inc, New York, NY, United States., Snyder M; Curex Inc, New York, NY, United States., Hakobyan B; Medical Research & Biostatistics, Arx Sciartis LLC, Chicago, IL, United States.
Source: Frontiers in allergy [Front Allergy] 2026 Jun 10; Vol. 7, pp. 1865860. Date of Electronic Publication: 2026 Jun 10 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2673-6101
DOI:10.3389/falgy.2026.1865860